Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
376.78 USD | -0.22% |
|
-0.22% | +25.67% |
30/06 | HCA Healthcare, Inc.(NYSE:HCA) added to Russell 1000 Value-Defensive Index | CI |
30/06 | HCA Healthcare, Inc.(NYSE:HCA) added to Russell 1000 Growth-Defensive Index | CI |
Projected Income Statement: HCA Healthcare, Inc.
Annual
Quarterly
Annual
Quarterly
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 51,533 | 58,752 | 60,233 | 64,968 | 70,603 | 74,732 | 78,512 | 82,642 |
Change | - | 14.01% | 2.52% | 7.86% | 8.67% | 5.85% | 5.06% | 5.26% |
EBITDA 1 | 10,037 | 12,644 | 12,067 | 12,726 | 13,882 | 14,833 | 15,518 | 16,386 |
Change | - | 25.97% | -4.56% | 5.46% | 9.08% | 6.85% | 4.62% | 5.59% |
EBIT 1 | 7,316 | 9,791 | 9,098 | 9,649 | 10,570 | 11,291 | 11,822 | 12,489 |
Change | - | 33.83% | -7.08% | 6.06% | 9.55% | 6.82% | 4.7% | 5.64% |
Interest Paid 1 | -1,584 | -1,566 | -1,741 | -1,938 | -2,061 | -2,269 | -2,341 | -2,411 |
Earnings before Tax (EBT) 1 | 5,430 | 9,833 | 8,580 | 7,706 | 8,523 | 9,118 | 9,592 | 10,229 |
Change | - | 81.09% | -12.74% | -10.19% | 10.6% | 6.98% | 5.2% | 6.64% |
Net income 1 | 3,754 | 6,956 | 5,643 | 5,242 | 5,760 | 6,175 | 6,480 | 6,943 |
Change | - | 85.3% | -18.88% | -7.11% | 9.88% | 7.21% | 4.93% | 7.15% |
Announcement Date | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: HCA Healthcare, Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 29,211 | 33,128 | 37,176 | 38,658 | 41,098 | 44,631 | 45,450 | 45,688 |
Change | - | 13.41% | 12.22% | 3.99% | 6.31% | 8.6% | 1.84% | 0.52% |
Announcement Date | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: HCA Healthcare, Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 2,835 | 3,577 | 4,395 | 4,744 | 4,875 | 5,094 | 5,260 | 5,486 |
Change | - | 26.17% | 22.87% | 7.94% | 2.76% | 4.5% | 3.25% | 4.31% |
Free Cash Flow (FCF) 1 | 6,397 | 5,382 | 4,127 | 4,687 | 5,639 | 6,262 | 6,170 | 7,185 |
Change | - | -15.87% | -23.32% | 13.57% | 20.31% | 11.05% | -1.47% | 16.46% |
Announcement Date | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | - | - | - |
1USD in Million
Estimates
Forecast Financial Ratios: HCA Healthcare, Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 19.48% | 21.52% | 20.03% | 19.59% | 19.66% | 19.85% | 19.77% | 19.83% |
EBIT Margin (%) | 14.2% | 16.66% | 15.1% | 14.85% | 14.97% | 15.11% | 15.06% | 15.11% |
EBT Margin (%) | 10.54% | 16.74% | 14.24% | 11.86% | 12.07% | 12.2% | 12.22% | 12.38% |
Net margin (%) | 7.28% | 11.84% | 9.37% | 8.07% | 8.16% | 8.26% | 8.25% | 8.4% |
FCF margin (%) | 12.41% | 9.16% | 6.85% | 7.21% | 7.99% | 8.38% | 7.86% | 8.69% |
FCF / Net Income (%) | 170.4% | 77.37% | 73.13% | 89.41% | 97.9% | 101.41% | 95.22% | 103.49% |
Profitability | ||||||||
ROA | 8.11% | 14.16% | 10.94% | 9.46% | 9.95% | 10.21% | 10.21% | 10.43% |
ROE | - | 352.48% | - | - | - | 279.4% | 148.5% | 104% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 2.91x | 2.62x | 3.08x | 3.04x | 2.96x | 3.01x | 2.93x | 2.79x |
Debt / Free cash flow | 4.57x | 6.16x | 9.01x | 8.25x | 7.29x | 7.13x | 7.37x | 6.36x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 5.5% | 6.09% | 7.3% | 7.3% | 6.9% | 6.82% | 6.7% | 6.64% |
CAPEX / EBITDA (%) | 28.25% | 28.29% | 36.42% | 37.28% | 35.12% | 34.34% | 33.89% | 33.48% |
CAPEX / FCF (%) | 44.32% | 66.46% | 106.49% | 101.22% | 86.45% | 81.35% | 85.25% | 76.35% |
Items per share | ||||||||
Cash flow per share 1 | 26.87 | 27.25 | 28.92 | 34.12 | 40.16 | 38.94 | 42.48 | 50.44 |
Change | - | 1.43% | 6.13% | 17.97% | 17.7% | -3.04% | 9.09% | 18.73% |
Dividend per Share 1 | 0.43 | 1.92 | 2.24 | 2.4 | 2.64 | 2.839 | 2.948 | 3.03 |
Change | - | 346.51% | 16.67% | 7.14% | 10% | 7.55% | 3.84% | 2.76% |
Book Value Per Share 1 | 1.665 | -2.838 | -9.39 | -6.681 | -9.997 | -16.75 | -12.58 | -6.346 |
Change | - | -270.48% | -230.88% | 28.85% | -49.63% | -67.52% | 24.86% | 49.56% |
EPS 1 | 10.93 | 21.16 | 19.15 | 18.97 | 22 | 25.32 | 28.15 | 31.92 |
Change | - | 93.6% | -9.5% | -0.94% | 15.97% | 15.09% | 11.19% | 13.39% |
Nbr of stocks (in thousands) | 3,38,375 | 3,11,023 | 2,82,717 | 2,67,661 | 2,53,297 | 2,40,574 | 2,40,574 | 2,40,574 |
Announcement Date | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | - | - | - |
1USD
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 14.9x | 13.4x |
PBR | -22.5x | -30x |
EV / Sales | 1.81x | 1.74x |
Yield | 0.75% | 0.78% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
377.60USD
Average target price
389.15USD
Spread / Average Target
+3.06%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCA Stock
- Financials HCA Healthcare, Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition